Latest news
Cytosorbents Advances Toward Operating Cash Flow Breakeven - TipRanksTipRanks · Fri, 07 Aug 2026 21:04:30 GMTAvita Medical Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 10:03:47 GMTAVITA Medical Reports Revenue Growth and Targets Cash Flow Breakeven in 2026 - KalkineKalkine · Fri, 07 Aug 2026 03:35:00 GMTAVITA Medical expects cash flow breakeven in fourth quarter 2026 - Stock TitanStock Titan · Thu, 06 Aug 2026 23:06:21 GMTRCEL: Q2 2026 revenue up 18% year-over-year; cash flow breakeven expected by Q4 2026 - TradingViewTradingView · Thu, 06 Aug 2026 20:40:50 GMTRCEL: Q2 revenue up 18% year-over-year, guidance raised, and cash flow breakeven expected in Q4 2026 - TradingViewTradingView · Thu, 06 Aug 2026 20:14:05 GMTAVITA Medical Q2 revenue rises 18% to $21.7M; raises 2026 guidance, expects Q4 cash-flow breakeven - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMTAVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:02:00 GMT